Air Liquide consensus stays supportive, shares sit below analyst targets
23.06.2026 - 15:19:33 | ad-hoc-news.de
By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-23, 15:17.
Air Liquide (FR0000120073) remains a core name on Euronext Paris under the ticker AI, trading recently around 165 to 166 euros according to exchange data for AI.PA. Consensus figures compiled by analyst platforms show average 12-month price targets near 181 euros, leaving a visible gap to the current level, based on data for Paris-listed Air Liquide shares.
What analysts are saying now
Across major houses tracked by Investing.com, 20 analysts currently cover Air Liquide, with 17 recommending Buy, 2 Hold and 1 Sell, giving the stock an overall Buy consensus rating as of late June 2026. Analyst consensus data on Investing.com The same compilation reports an average 12-month price target of 181.10 euros, with the highest estimate at 200 euros and the lowest at 152.73 euros, indicating analysts see upside from the current Euronext Paris quotation.
Alongside the broad-based consensus, individual houses have refreshed their views in recent weeks. Goldman Sachs reiterated its Buy rating on Air Liquide on 9 June 2026 and set a price target of 179 euros, according to a summary of the bank’s update reported by finanzen.ch. Goldman Sachs rating summary via finanzen.ch Deutsche Bank followed on 18 June 2026 by reaffirming its Buy stance while trimming its price target to 190 euros from a previously higher level, as noted in a Marketscreener-based digest of analyst actions on the stock. Analyst target overview on MarketScreener
How current price compares to targets
With Air Liquide shares quoted around 165.70 euros on Euronext Paris in mid-June, the average 181.10-euro target from the 20-analyst panel implies potential upside of just over 9 percent from the spot level, Investing.com calculates. Investing.com target and upside figures That upside estimate reflects the distance between the prevailing market price and the consensus target rather than a forecast of short-term performance.
MarketScreener’s aggregation of broker views paints a similar picture, with many published targets clustering in the high 170s to low 190s per share, still clearly above recent trading around the mid-160s euros. MarketScreener consensus and target cluster In this context, the Deutsche Bank and Goldman Sachs targets slot into the upper half of the range, underlining a broadly constructive stance on the stock among large research houses that follow European industrial gases and chemicals peers such as Linde and Air Products.
All news and analysis on the Air Liquide shares
Further updates on analyst opinions, price moves and corporate disclosures for Air Liquide can be followed on the dedicated topic page and via the company’s Investor Relations site.
How Air Liquide makes its money
Air Liquide generates most of its revenue by supplying industrial gases such as oxygen, nitrogen and hydrogen to customers in sectors including chemicals, refining, metals, electronics and healthcare, often via long-term contracts and pipeline networks. The company also runs a sizeable Healthcare business, providing medical gases and home healthcare services to patients with chronic respiratory conditions across Europe and other regions, alongside engineering and construction activities for gas production and processing units.
Where the stock trades today
The Air Liquide shares (FR0000120073) trade on Euronext Paris under the ticker AI at about 165.70 euros as of 2026-06-18, 16:30, based on recent quote information for AI.PA.
Key data on the Air Liquide shares
- Company: L'Air Liquide S.A.
- ISIN: FR0000120073
- WKN: 850133
- Ticker: AI
- Trading venue: Euronext Paris
- Price (as of 2026-06-18, 16:30): 165.70 EUR
- Market cap: approximately 96 billion EUR (as of mid-June 2026)
- Sector / industry: Industrials / Industrial Gases & Chemicals
- Index membership: CAC 40
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any financial instrument. Investors should conduct their own research or consult a qualified financial advisor before making investment decisions.
